Usefulness of Sodium-Glucose Cotransporter 2 Inhibitors for Primary Prevention of Heart Failure in Patients With Type 2 Diabetes Mellitus
Ronen Arbel, Enis Aboalhasan, Ariel Hammerman, Joseph Azuri
Topics & Concepts
EmpagliflozinCanagliflozinDapagliflozinMedicineRandomized controlled trialDiabetes mellitusInternal medicineIntensive care medicineType 2 Diabetes MellitusHazard ratioEmergency medicineConfidence intervalEndocrinologyDiabetes Treatment and ManagementPancreatic function and diabetesDiabetes Management and Research